Musculoskeletal manifestations in polymyalgia rheumatica and temporal arteritis.

To evaluate the incidence and characteristics of musculoskeletal manifestations in polymyalgia rheumatica (PMR) and temporal arteritis (TA). METHODS The records of 163 cases of PMR or TA diagnosed over a 15 year period in one area of Spain were reviewed for the presence and type of musculoskeletal manifestations. RESULTS Of 163 patients, 90 had isolated PMR and 73 had TA. Eighteen of the 90 patients (20%) with isolated PMR developed distal peripheral arthritis either at diagnosis or during the course of the disease. When it occurred, synovitis was mild, monoarticular or pauci-articular, asymmetrical, transient, and not destructive. Other distal manifestations observed in these patients were carpal tunnel syndrome and distal extremity swelling with pitting oedema. In all cases these manifestations occurred in conjunction with active PMR. As expected, PMR was the most frequent musculoskeletal manifestation in patients with TA, occurring in 56% of cases. On the contrary, only 11% of patients with TA developed peripheral arthritis. An important finding was that peripheral arthritis in these patients appears to be linked only temporally to the presence of simultaneous PMR and is not observed in its absence. Distal extremity swelling or defined polyarthritis were not observed. CONCLUSION The spectrum of distal musculoskeletal manifestations of PMR in our series is similar to that reported in other populations. By contrast, distal musculoskeletal symptoms are uncommon in TA. The almost complete absence of distal musculoskeletal manifestations in patients with pure TA suggests different mechanisms of disease in PMR and TA, supporting the view of two separate conditions or one common disease in which host susceptibility influences the clinical expression.

Value of clinical factors in selecting postmenopausal women with rheumatoid arthritis for bone densitometry.

Criteria to decide which patients with rheumatoid arthritis (RA) should be examined by dual energy x ray absorptiometry (DXA) are currently not available. The rheumatologists from Amsterdam have proposed preliminary criteria based on clinical risk factors (age, disease activity, and functional status). These criteria are preliminary and not widely accepted but might be helpful in practice. The value of the proposal in a group of Spanish postmenopausal women with RA is analysed. METHODS DXA (lumbar spine and femoral neck) was performed in 128 patients recruited from a clinical setting, and the proposed criteria were applied. T and Z scores were established for a Spanish reference population. RESULTS The mean (SD) age of the patients was 61.3 (10.7) and mean duration of the postmenopausal period 14.5 (10.1) years. Mean duration of RA was 13.7 (7.7) years. Mean C reactive protein was 22 (21) mg/l; mean erythrocyte sedimentation rate 26 (18) mm/1st h; and mean Health Assessment Questionnaire score 1.25 (0.79). Ninety (70%) patients fulfilled the proposed criteria. Their sensitivity for the diagnosis of osteoporosis (T score ¿¿2.5 SD) was 86% and their specificity, 43%. Positive predictive value was 54% and negative predictive value, 79%. CONCLUSIONS The proposed criteria seem a good screening method for the selection of those patients with RA whose bone mineral density should be assessed as the sensitivity and negative predictive value are acceptable.

Role of technetium-99m diphosphonate and gallium-67 citrate bone scanning in the early diagnosis of infectious spondylodiscitis: a comparative study

A comparative study of the parts played by technetium-99m diphosphonate and gallium-67 citrate bone scanning in the early diagnosis of infectious spondylodiscitis is presented. Nineteen patients were included in the study. All patients (11 men aged 19-70 years and eight women aged 18-72 years) had a history of back pain varying in duration from one to 15 weeks. A 99mTc diphosphonate bone scan was positive in 17 patients. The two patients with negative results had less than two weeks of back pain. The 67Ga citrate bone scan showed uptake in all patients.

Elaboración de un video sobre calidad, seguridad y medio ambiente en la Unidad de Laboratorios Docentes (ULD) de la Facultad de Farmacia de la Universidad de Barcelona

La Unidad de Laboratorios Docentes (ULD) de la Facultad de Farmacia (UB) ha implantado un sistema de gestión de la calidad (SGC) que permite transmitir al estudiante una formación adicional con el objetivo de mejorar sus competencias transversales (siguiendo las directrices del Espacio Europeo de Educación Superior, EEES). Además, en el curso académico 06-07, se instauraron las Buenas Prácticas Ambientales (BPAL) para disponer de un sistema de gestión que incorporase los criterios de calidad, medioambiente y seguridad (sistema de gestión integrada, SGI). Durante el presente curso académico se ha procedido a la grabación y edición de un video sobre calidad, seguridad y medioambiente en la ULD con el objetivo de mejorar la formación transversal de los estudiantes facilitando la integración de los conocimientos y habilidades profesionales. De esta forma, al salir del entorno universitario, los licenciados y graduados de la Facultad de Farmacia dispondrán de un valor añadido en su formación, mejorando así sus competencias para el desarrollo de su futura profesión. En el video se muestra la manera de trabajar correctamente según las normas de calidad, seguridad y medioambiente recogidas además en un tríptico que se entrega a los estudiantes al acceder por primera vez a un laboratorio de prácticas. El video se difundirá a través de la página web de la ULD, de la videoteca de la UB, del canal You Tube Canal UB, así como de las asignaturas que lo soliciten (sirviendo de soporte para el personal docente).

Unconventional magnetic behavior of iron-oxide nanoparticles in polymeric matrices

We report the results of magnetization and 57Fe Mössbauer spectroscopy measurements performed in the temperature range 5-300 K on composites containing iron¿oxide nanoparticles encased in polystyrene type resins. After carrying out a suitable field treatment in order to decouple the particles from the matrix, a fraction of the particles freely rotate in response to an applied magnetic field

Community pharmacist intervention in depressed primary care patients (PRODEFAR study): randomized controlled trial protocol.

Background: Treatment of depression, the most prevalent and costly mental disorder, needs to be improved. Non-concordance with clinical guidelines and non-adherence can limit the efficacy of pharmacological treatment of depression. Through pharmaceutical care, pharmacists can improve patients' compliance and wellbeing. The aim of this study is to evaluate the effectiveness and costeffectiveness of a community pharmacist intervention developed to improve adherence and outcomes of primary care patients with depression. Methods/design: A randomized controlled trial, with 6-month follow-up, comparing patients receiving a pharmaceutical care support programme in primary care with patients receiving usual care. The total sample comprises 194 patients (aged between 18 and 75) diagnosed with depressive disorder in a primary care health centre in the province of Barcelona (Spain). Subjects will be asked for written informed consent in order to participate in the study. Diagnosis will be confirmed using the SCID-I. The intervention consists of an educational programme focused on improving knowledge about medication, making patients aware of the importance of compliance, reducing stigma, reassuring patients about side-effects and stressing the importance of carrying out general practitioners' advice. Measurements will take place at baseline, and after 3 and 6 months. Main outcome measure is compliance with antidepressants. Secondary outcomes include; clinical severity of depression (PHQ-9), anxiety (STAI-S), health-related quality of life (EuroQol-5D), satisfaction with the treatment received, side-effects, chronic physical conditions and sociodemographics. The use of healthcare and social care services will be assessed with an adapted version of the Client Service Receipt Inventory (CSRI). Discussion: This trial will provide valuable information for health professionals and policy makers on the effectiveness and cost-effectiveness of a pharmaceutical intervention programme in the context of primary care. Trial registration: NCT00794196

Elaboración de un video sobre calidad, seguridad y medio ambiente en la Unidad de Laboratorios Docentes (ULD) de la Facultad de Farmacia de la Universidad de Barcelona

La Unidad de Laboratorios Docentes (ULD) de la Facultad de Farmacia (UB) ha implantado un sistema de gestión de la calidad (SGC) que permite transmitir al estudiante una formación adicional con el objetivo de mejorar sus competencias transversales (siguiendo las directrices del Espacio Europeo de Educación Superior, EEES). Además, en el curso académico 06-07, se instauraron las Buenas Prácticas Ambientales (BPAL) para disponer de un sistema de gestión que incorporase los criterios de calidad, medioambiente y seguridad (sistema de gestión integrada, SGI). Durante el presente curso académico se ha procedido a la grabación y edición de un video sobre calidad, seguridad y medioambiente en la ULD con el objetivo de mejorar la formación transversal de los estudiantes facilitando la integración de los conocimientos y habilidades profesionales. De esta forma, al salir del entorno universitario, los licenciados y graduados de la Facultad de Farmacia dispondrán de un valor añadido en su formación, mejorando así sus competencias para el desarrollo de su futura profesión. En el video se muestra la manera de trabajar correctamente según las normas de calidad, seguridad y medioambiente recogidas además en un tríptico que se entrega a los estudiantes al acceder por primera vez a un laboratorio de prácticas. El video se difundirá a través de la página web de la ULD, de la videoteca de la UB, del canal You Tube Canal UB, así como de las asignaturas que lo soliciten (sirviendo de soporte para el personal docente).